Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
sicklecellanemianews
7h
Pfizer withdraws Oxbryta from global markets, cites safety concerns
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Iran launches missile attack
FL homeless law kicks in
Helene wreaks havoc
How to watch VP debate
Tony-winning star dies
Kentucky sheriff steps down
Pledges support for Ukraine
Explosive devices found
Settlement checks delayed
Broadway star dies at 70
TX fraud probe shut down
Asylum restrictions extended
Arkansas sues YouTube
More troops to Middle East
To lay off 2,900 employees
GA abortion ban blocked
Breast cancer deaths fall
Wausau drop box replaced
FCC probing outage
Jimmy Carter turns 100
'Pled guilty to journalism'
Japan's new prime minister
CA bans legacy admissions
Gonzaga set to join PAC-12
Top Adams aide resigns
194K Jeep SUVs recalled
US sanctions settler group
Feedback